3 Growth Companies Insiders Own With Earnings Growth Up To 90%

As global markets react to accelerating U.S. inflation and the potential for reciprocal tariffs, growth stocks have been outperforming their value counterparts, with major indices like the Nasdaq Composite nearing record highs. In this environment, companies with high insider ownership can be particularly appealing as they often signal confidence in future earnings potential; here we explore three such growth companies that boast impressive earnings growth rates of up to 90%.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3)	17.3%	22.8%
Seojin SystemLtd (KOSDAQ:A178320)	32.1%	39.9%
Clinuvel Pharmaceuticals (ASX:CUV)	10.4%	26.2%
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
Propel Holdings (TSX:PRL)	36.5%	38.7%
CD Projekt (WSE:CDR)	29.7%	39.4%
On Holding (NYSE:ONON)	19.1%	29.9%
Pharma Mar (BME:PHM)	11.9%	45.4%
Elliptic Laboratories (OB:ELABS)	26.8%	121.1%
Fulin Precision (SZSE:300432)	13.6%	71%

Click here to see the full list of 1460 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Nanjing Vazyme Biotech (SHSE:688105)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Nanjing Vazyme Biotech Co., Ltd provides technology solutions in life science, biomedicine, and in vitro diagnostics with a market cap of CN¥8.71 billion.

Operations: Nanjing Vazyme Biotech Co., Ltd generates revenue through its offerings in life science, biomedicine, and in vitro diagnostics.

Insider Ownership: 12.8%

Earnings Growth Forecast: 90% p.a.

Nanjing Vazyme Biotech is experiencing rapid growth, with earnings forecasted to increase by 90% annually, significantly outpacing the Chinese market. Revenue is also expected to grow at 23.7% per year. The company recently completed a share buyback program worth CNY 106 million, enhancing shareholder value. Despite these positives, the company's return on equity is projected to remain low at 7.3% in three years, which may impact overall financial performance quality.

• Get an in-depth perspective on Nanjing Vazyme Biotech's performance by reading our analyst estimates report here.
• Our expertly prepared valuation report Nanjing Vazyme Biotech implies its share price may be too high.

Henan Shijia Photons Technology (SHSE:688313)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Henan Shijia Photons Technology Co., Ltd. operates in the photonics industry and has a market capitalization of approximately CN¥8.89 billion.

Operations: The company generates revenue of CN¥942.76 million from its Optical Networking Equipments segment.

Insider Ownership: 10.1%

Earnings Growth Forecast: 65.9% p.a.

Henan Shijia Photons Technology is poised for substantial growth, with earnings expected to increase by 65.9% annually, surpassing the Chinese market's average. Revenue is forecasted to grow at 22.1% per year, also outpacing market expectations. The company has recently turned profitable and maintains high-quality earnings despite large one-off items affecting results. However, its return on equity is projected to be relatively low at 9.2% in three years, and the share price has been highly volatile recently.

• Take a closer look at Henan Shijia Photons Technology's potential here in our earnings growth report.
• The valuation report we've compiled suggests that Henan Shijia Photons Technology's current price could be inflated.

init innovation in traffic systems (XTRA:IXX)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Init innovation in traffic systems SE, along with its subsidiaries, provides intelligent transportation systems solutions for public transportation globally and has a market cap of €367.39 million.

Operations: The company generates revenue from its Wireless Communications Equipment segment, totaling €245.89 million.

Insider Ownership: 39.6%

Earnings Growth Forecast: 27.8% p.a.

Init innovation in traffic systems is positioned for growth, with earnings projected to grow significantly at 27.78% annually, outpacing the German market's average. The company trades at a good value, 16.9% below its estimated fair value, and has shown strong past performance with a 25% earnings increase over the last year. However, its revenue growth forecast of 12.3% per year lags behind its profit growth and the dividend yield of 1.88% is not well covered by free cash flows.

• Click to explore a detailed breakdown of our findings in init innovation in traffic systems' earnings growth report.
• Our comprehensive valuation report raises the possibility that init innovation in traffic systems is priced lower than what may be justified by its financials.

Make It Happen

• Embark on your investment journey to our 1460 Fast Growing Companies With High Insider Ownership selection here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com